- RecruitingPHASE1, PHASE2
Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors
This study is testing a new medicine, TH9619, for people with advanced cancers like bowel, head and neck, lung, and stomach cancer. It's the first time TH9619 is being given to people, and doctors want to find the safest and most effective dose.
For: Solid Tumor · Colorectal Cancer (CRC) · Squamous Cell Carcinoma of Head and NeckFrance · Spain · United Kingdom - RecruitingPhase I
A first-in-human, phase 1/2, multicenter, open-label, dose escalation, confirmation and expansion study to evaluate the safety, pharmacokinetics and antitumor activity of TH9619 in subjects with advanced solid tumors (ODIN)
This study is testing a new drug, TH9619, for people with advanced cancer. It's the first time it’s being given to humans, aiming to see if it’s safe, how it works in the body, and if it can help fight cancer.
For: Advanced solid tumorsUnited Kingdom · France · Spain